These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34873465)

  • 1. An unprecedented endocrine target for ovarian cancer: inhibiting 17β-HSD7 supresses cancer cell proliferation and arrests G2/M cycle.
    Wang R; Li T; Li G; Lin SX
    Am J Cancer Res; 2021; 11(11):5358-5373. PubMed ID: 34873465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic control of sex hormones by 17β-HSD type 7: a novel target for estrogen-dependent breast cancer.
    Wang X; Gérard C; Thériault JF; Poirier D; Doillon CJ; Lin SX
    J Mol Cell Biol; 2015 Dec; 7(6):568-79. PubMed ID: 25966904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutual regulations and breast cancer cell control by steroidogenic enzymes: Dual sex-hormone receptor modulation upon 17β-HSD7 inhibition.
    Sang X; Han H; Li T; Lin SX
    J Steroid Biochem Mol Biol; 2019 Oct; 193():105411. PubMed ID: 31207361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reductive 17beta-hydroxysteroid dehydrogenases which synthesize estradiol and inactivate dihydrotestosterone constitute major and concerted players in ER+ breast cancer cells.
    Zhang CY; Wang WQ; Chen J; Lin SX
    J Steroid Biochem Mol Biol; 2015 Jun; 150():24-34. PubMed ID: 25257817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate inhibition of 17β-HSD1 in living cells and regulation of 17β-HSD7 by 17β-HSD1 knockdown.
    Han H; Thériault JF; Chen G; Lin SX
    J Steroid Biochem Mol Biol; 2017 Sep; 172():36-45. PubMed ID: 28554725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and characterization of human form 2 type 7 17beta-hydroxysteroid dehydrogenase, a primarily 3beta-keto reductase and estrogen activating and androgen inactivating enzyme.
    Liu H; Robert A; Luu-The V
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):173-9. PubMed ID: 15862963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of 17beta-hydroxysteroid dehydrogenase type 7 modulates breast cancer protein profile and enhances apoptosis by down-regulating GRP78.
    Wang XQ; Aka JA; Li T; Xu D; Doillon CJ; Lin SX
    J Steroid Biochem Mol Biol; 2017 Sep; 172():188-197. PubMed ID: 28645527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dual sex hormone specificity for human reductive 17β-hydroxysteroid dehydrogenase type 7: Synergistic function in estrogen and androgen control.
    Thériault JF; Lin SX
    J Steroid Biochem Mol Biol; 2019 Feb; 186():61-65. PubMed ID: 30227243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of SNP variants in the 17β-HSD2 and 17β-HSD7 genes and 17β-HSD7 copy number on gene transcript and estradiol levels in breast cancer tissue.
    Straume AH; Knappskog S; Lønning PE
    J Steroid Biochem Mol Biol; 2014 Sep; 143():192-8. PubMed ID: 24560990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid sulfatase inhibition success and limitation in breast cancer clinical assays: An underlying mechanism.
    Sang X; Han H; Poirier D; Lin SX
    J Steroid Biochem Mol Biol; 2018 Oct; 183():80-93. PubMed ID: 29803725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting macrophagic 17
    Dong X; Feng Y; Xu D; Zhang M; Wen X; Zhao W; Hu Q; Zhang Q; Fu H; Ping J
    Acta Pharm Sin B; 2023 Jan; 13(1):142-156. PubMed ID: 36815031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.
    Bellavance E; Luu-The V; Poirier D
    J Med Chem; 2009 Dec; 52(23):7488-502. PubMed ID: 19772289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking 17β-hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach.
    Konings GF; Cornel KM; Xanthoulea S; Delvoux B; Skowron MA; Kooreman L; Koskimies P; Krakstad C; Salvesen HB; van Kuijk K; Schrooders YJ; Vooijs M; Groot AJ; Bongers MY; Kruitwagen RF; ; Romano A
    J Pathol; 2018 Feb; 244(2):203-214. PubMed ID: 29144553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 17beta-hydroxysteroid dehydrogenase type 7--an ancient 3-ketosteroid reductase of cholesterogenesis.
    Breitling R; Krazeisen A; Möller G; Adamski J
    Mol Cell Endocrinol; 2001 Jan; 171(1-2):199-204. PubMed ID: 11165030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of Diallyl Disulfide on the Proliferation and Apoptosis of Epithelial Ovarian Cancer Cells by Inducing G2/M Arrest].
    Zhang RT; Shi HR; Ren F; Liu ZY; Ji PC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Feb; 41(1):43-52. PubMed ID: 30837041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17beta-hydroxysteroid dehydrogenase type 1 stimulates breast cancer by dihydrotestosterone inactivation in addition to estradiol production.
    Aka JA; Mazumdar M; Chen CQ; Poirier D; Lin SX
    Mol Endocrinol; 2010 Apr; 24(4):832-45. PubMed ID: 20172961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in luteal production of androstenedione, testosterone, and estrone, but not estradiol, during mid- and late pregnancy in pigs: effects of androgen deficiency.
    Grzesiak M; Knapczyk-Stwora K; Ciereszko RE; Wieciech I; Slomczynska M
    Theriogenology; 2014 Sep; 82(5):720-33. PubMed ID: 25011982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mimicking postmenopausal steroid metabolism in breast cancer cell culture: Differences in response to DHEA or other steroids as hormone sources.
    Xu D; Lin SX
    J Steroid Biochem Mol Biol; 2016 Jul; 161():92-100. PubMed ID: 26200948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estradiol regulates gonadotropin-releasing hormone (GnRH) and its receptor gene expression and antagonizes the growth inhibitory effects of GnRH in human ovarian surface epithelial and ovarian cancer cells.
    Kang SK; Choi KC; Tai CJ; Auersperg N; Leung PC
    Endocrinology; 2001 Feb; 142(2):580-8. PubMed ID: 11159828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution to the development of inhibitors of 17β-hydroxysteroid dehydrogenase types 1 and 7: key tools for studying and treating estrogen-dependent diseases.
    Poirier D
    J Steroid Biochem Mol Biol; 2011 May; 125(1-2):83-94. PubMed ID: 21182944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.